Pharmazon has received a minority investment from a private investor

The shareholders of Pharmazon have sold the company to a private investor.

Pharmazon is a B2B distributor of OTC and parapharmacy products to French pharmacies. Its core business is to buy products directly from laboratories, negotiating good conditions and selling them online through a modern website which looks similar to Amazon.com.

The company's shareholders are the CEO and General Director.

Oaklins' team in France advised the seller in this transaction.

Service

M&A sell-side

Parties

Talk to the deal team

Ludovic Beaulieu

Partner

Paris, France
Oaklins France

View profile Get in touch

Antoine Lemaire

Partner

Paris, France
Oaklins France

View profile Get in touch

Related deals

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market

Financial Services | Healthcare

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market

Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.

Learn more

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more

Afric Phar has been acquired by Pharma Capital

Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more